COVINGTON, Ky., Jan. 6, 2026 /PRNewswire/ -- Bexion Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing a novel class of biologic therapy to treat solid tumor cancers and chemotherapy-induced peripheral neuropathy (CIPN), today announced that the Company will...
Hence then, the article about bexion pharmaceuticals inc announces poster presentations at the american society for clinical oncology asco gastrointestinal cancers symposium 2026 was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Bexion Pharmaceuticals, Inc. Announces Poster Presentations at the American Society for Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium 2026 )
Also on site :
- We Finally Paid Off Our Last Piece of Debt. I Didn’t Expect It to Backfire Like This.
- US seizes Russian oil tanker in North Atlantic
- More than 700 to be laid off as U.S. Postal Service terminates contract for Aurora mail hub